13F Holdings
中文EN

STE STERIS plc

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1757898 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.1%
TTM net income YoY20.1%
TTM EPS YoY21.7%
Revenue 3-yr CAGR8.6%
Net income 3-yr CAGR14.6%

Margins

Gross margin44.6%
Operating margin19.0%
Net margin13.4%
FCF margin15.2%
EBITDA margin27.0%

Returns

ROE11.6%
ROA7.8%
ROIC (approx.)10.0%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets32.1%
Debt / equity0.26x
Current ratio2.05x
Interest coverage20.53x

Cash quality & payout

Operating cash flow / net income1.56x
Accruals ratio-4.4%
Payout ratio30.5%
Capex / revenue5.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31
Income statement
Revenue$5.94B$5.46B$5.14B$4.54B$4.22B
Cost of revenue$3.31B$3.06B$2.92B$2.56B$2.34B
Gross profit$2.63B$2.40B$2.22B$1.98B$1.88B
R&D expense$112.90M$107.60M$103.70M$98.48M$86.66M
SG&A expense$1.41B$1.33B$1.25B$1.09B$1.32B
Operating income$1.10B$866.60M$836.10M$791.10M$477.81M
Interest expense$60.70M$86.30M$144.40M$107.96M$89.49M
Pretax income$1.05B$796.20M$702.80M$680.27M$366.80M
Income tax$262.20M$184.70M$149.50M$124.07M$82.34M
Net income$782.30M$614.60M$378.20M$107.03M$243.89M
EBITDA$1.59B$1.34B$1.40B$1.34B$1.03B
EPS (basic)7.976.243.831.072.50
EPS (diluted)7.936.203.811.072.48
Dividends declared per share2.462.232.031.841.69
Weighted avg. shares (diluted)98.70M99.10M99.40M100.25M98.33M
Balance sheet
Cash & equivalents$439.60M$171.70M$207.00M$208.40M$348.32M
Receivables$1.09B$1.04B$1.01B$864.99M$799.04M
Inventory$631.80M$581.30M$674.53M$604.41M$575.00M
Current assets$2.39B$2.00B$2.87B$2.01B$1.88B
PP&E, net$2.16B$1.96B$1.77B$1.63B$1.55B
Goodwill$4.19B$4.10B$4.07B$3.88B$3.94B
Intangibles$1.62B$1.85B$2.12B$2.08B$3.33B
Total assets$10.74B$10.15B$11.06B$10.82B$11.42B
Current liabilities$1.15B$1.02B$931.13M$861.84M$922.22M
Short-term debt$118.90M$125.00M$85.94M$60.00M$142.88M
Long-term debt$1.81B$1.92B$3.12B$3.02B$2.95B
Total debt$1.93B$2.04B$3.21B$3.08B$3.09B
Total liabilities$3.54B$3.53B$4.75B$4.73B$4.88B
Shareholders' equity$7.18B$6.60B$6.30B$6.08B$6.53B
Net debt$1.49B$1.87B$3.00B$2.87B$2.74B
Shares outstanding97.80M98.30M98.88M98.63M100.07M
Cash flow statement
Operating cash flow$1.34B$1.15B$973.30M$756.95M$684.81M
Capital expenditure$369.00M$370.10M$360.30M$361.97M$287.56M
Free cash flow$972.40M$778.00M$613.00M$394.98M$397.25M
Investing cash flow-$512.50M$388.80M-$887.40M-$383.33M-$666.56M
Financing cash flow-$568.20M-$1.57B-$85.20M-$498.72M$115.83M
Depreciation & amortization$486.50M$476.20M$565.20M$552.90M$553.10M
Stock-based compensation$61.70M$57.40M$56.50M$38.95M$57.66M
Dividends paid$241.80M$219.90M$200.60M$183.50M$163.17M
Share buybacks$235.50M$211.30M$11.80M$308.56M$55.78M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.